Elimination of both CD4+ and CD8+ T cells but not B cells eliminates inflammation and prolongs the survival of TGFβ1-deficient mice

被引:19
作者
Bommireddy, R
Engle, SJ
Ormsby, I
Boivin, GP
Babcock, GF
Doetschman, T [1 ]
机构
[1] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA
[2] Aventis Pharmaceut Inc, Bridgewater, NJ 08807 USA
[3] Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA
[4] Univ Cincinnati, Coll Med, Dept Surg, Cincinnati, OH 45267 USA
[5] Shriners Hosp Children, Cincinnati, OH 45229 USA
关键词
cell proliferation; growth factors; inflammation; knockout mice; TGF beta 1; T-lymphocytes and B-lymphocytes;
D O I
10.1016/j.cellimm.2005.02.004
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Transforming growth factor beta 1 (TGF beta 1) is a potent negative immunoregulatory molecule. We have previously shown that the autoimmune-mediated weaning-age lethality of Tgfb1(-/-) mice is reversed upon genetic combination with Scid or Rag null alleles. Here, we show that elimination of T but not B cells is sufficient for the reversal, but elimination of either CD4(+) or CD8(+) cells is not. Although elimination of B cells does not rescue TGF beta 1-deficient animals from autoimmunity, B cells are hyperresponsive to LPS in the absence of TGF beta 1. TGF beta 1 deficiency leads to activation of CD8(+) T cells as suggested by down-modulation of CD8 even in the absence of CD4(+) T cells. This study provides evidence that both CD4(+) and CD8(+) T cells, but not B cells, have the ability to cause inflammation in the absence of TGF beta 1. However, though TGF beta 1-deficient B cells are hyperresponsive to stimulation, alone they are not sufficient to cause inflammation. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:96 / 104
页数:9
相关论文
共 37 条
[1]   Germ-free and barrier-raised TGF beta 1-deficient mice have similar inflammatory lesions [J].
Boivin, GP ;
JonesCarson, J ;
OToole, BA ;
Doetschman, T .
TRANSGENIC RESEARCH, 1997, 6 (03) :197-202
[2]   TGF-β, T-cell tolerance and anti-CD3 therapy [J].
Bommireddy, R ;
Doetschman, T .
TRENDS IN MOLECULAR MEDICINE, 2004, 10 (01) :3-9
[3]   TGFβ1 inhibits Ca2+-calcineurin-mediated activation in thymocytes [J].
Bommireddy, R ;
Ormsby, I ;
Yin, M ;
Boivin, GP ;
Babcock, GF ;
Doetschman, T .
JOURNAL OF IMMUNOLOGY, 2003, 170 (07) :3645-3652
[4]   TGF-β1 regulates lymphocyte homeostasis by preventing activation and subsequent apoptosis of peripheral lymphocytes [J].
Bommireddy, R ;
Saxena, V ;
Ormsby, I ;
Yin, MY ;
Boivin, GP ;
Babcock, GF ;
Singh, RR ;
Doetschman, T .
JOURNAL OF IMMUNOLOGY, 2003, 170 (09) :4612-4622
[5]   Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells [J].
Chambers, CA ;
Sullivan, TJ ;
Allison, JP .
IMMUNITY, 1997, 7 (06) :885-895
[6]   Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3 [J].
Chen, WJ ;
Jin, WW ;
Hardegen, N ;
Lei, KJ ;
Li, L ;
Marinos, N ;
McGrady, G ;
Wahl, SM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (12) :1875-1886
[7]  
Christianson GJ, 1996, J IMMUNOL, V156, P4932
[8]  
Christianson GJ, 1997, J IMMUNOL, V159, P4781
[9]  
DANG H, 1995, J IMMUNOL, V155, P3205
[10]  
DICKSON MC, 1995, DEVELOPMENT, V121, P1845